1. Home
  2. CGEM vs GPRE Comparison

CGEM vs GPRE Comparison

Compare CGEM & GPRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CGEM
  • GPRE
  • Stock Information
  • Founded
  • CGEM 2016
  • GPRE 2004
  • Country
  • CGEM United States
  • GPRE United States
  • Employees
  • CGEM N/A
  • GPRE N/A
  • Industry
  • CGEM Biotechnology: Pharmaceutical Preparations
  • GPRE Major Chemicals
  • Sector
  • CGEM Health Care
  • GPRE Industrials
  • Exchange
  • CGEM Nasdaq
  • GPRE Nasdaq
  • Market Cap
  • CGEM 730.2M
  • GPRE 684.0M
  • IPO Year
  • CGEM 2021
  • GPRE N/A
  • Fundamental
  • Price
  • CGEM $11.87
  • GPRE $9.13
  • Analyst Decision
  • CGEM Strong Buy
  • GPRE Strong Buy
  • Analyst Count
  • CGEM 7
  • GPRE 9
  • Target Price
  • CGEM $31.67
  • GPRE $26.06
  • AVG Volume (30 Days)
  • CGEM 514.5K
  • GPRE 1.1M
  • Earning Date
  • CGEM 11-07-2024
  • GPRE 02-05-2025
  • Dividend Yield
  • CGEM N/A
  • GPRE N/A
  • EPS Growth
  • CGEM N/A
  • GPRE N/A
  • EPS
  • CGEM N/A
  • GPRE N/A
  • Revenue
  • CGEM N/A
  • GPRE $2,587,166,000.00
  • Revenue This Year
  • CGEM N/A
  • GPRE N/A
  • Revenue Next Year
  • CGEM N/A
  • GPRE $8.25
  • P/E Ratio
  • CGEM N/A
  • GPRE N/A
  • Revenue Growth
  • CGEM N/A
  • GPRE N/A
  • 52 Week Low
  • CGEM $9.24
  • GPRE $9.12
  • 52 Week High
  • CGEM $30.19
  • GPRE $26.04
  • Technical
  • Relative Strength Index (RSI)
  • CGEM 41.20
  • GPRE 33.93
  • Support Level
  • CGEM $10.44
  • GPRE $9.12
  • Resistance Level
  • CGEM $12.79
  • GPRE $11.11
  • Average True Range (ATR)
  • CGEM 0.67
  • GPRE 0.56
  • MACD
  • CGEM 0.03
  • GPRE -0.13
  • Stochastic Oscillator
  • CGEM 45.25
  • GPRE 0.41

About CGEM Cullinan Oncology Inc.

Cullinan Therapeutics Inc is a biopharmaceutical company. It has diversified portfolio of clinical-stage assets that inhibit key drivers of disease or harness the immune system to eliminate diseased cells in both oncology and autoimmune diseases. Its understanding of oncology, immunology, and translational medicine, create differentiated ideas, identify the appropriate targets, and select the optimal modality to develop transformative therapeutics across a variety of cancer and autoimmune indications.

About GPRE Green Plains Inc.

Green Plains Inc manufactures and sells ethanol and ethanol byproducts in three segments based on function. The ethanol production segment, which generates the majority of revenue, includes the production of ethanol, distillers grains, Ultra-High Protein and renewable corn oil. The agribusiness and energy services segment includes grain handling and storage, commodity marketing and merchant trading for company-produced and third-party ethanol, distillers grains, Ultra-High Protein, renewable corn oil, natural gas and other commodities. The partnership segment provides fuel storage and transportation services.

Share on Social Networks: